Anúncio
Anúncio

ELAN

ELAN logo

Elanco Animal Health Incorporated Common Stock

22.82
USD
Patrocinado
-0.98
-4.12%
07 de jan., 16:00 UTC -5
Encerrado
exchange

Pós-Mercado

22.88

+0.06
+0.27%

Relatórios de Lucros ELAN

Rácio de surpresa positiva

ELAN separação 24 de 29 últimas estimativas.

83%

Próximo Relatório

Data do Próximo Relatório
23 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.11B
/
$0.11
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-1.98%
/
-42.11%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+9.26%
/
-21.43%

Elanco Animal Health Incorporated Common Stock earnings per share and revenue

On 05 de nov. de 2025, ELAN reported earnings of 0.19 USD per share (EPS) for Q3 25, beating the estimate of 0.13 USD, resulting in a 42.96% surprise. Revenue reached 1.14 bilhão, compared to an expected 1.11 bilhão, with a 2.11% difference. The market reacted with a -4.00% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 analistas forecast an EPS of 0.11 USD, with revenue projected to reach 1.11 bilhão USD, implying an diminuir of -42.11% EPS, and diminuir of -1.98% in Revenue from the last quarter.
FAQ
For Q3 2025, Elanco Animal Health Incorporated Common Stock reported EPS of $0.19, beating estimates by 42.96%, and revenue of $1.14B, 2.11% above expectations.
The stock price moved down -4%, changed from $22.50 before the earnings release to $21.60 the day after.
The next earning report is scheduled for 23 de fev. de 2026.
Based on 16 analistas, Elanco Animal Health Incorporated Common Stock is expected to report EPS of $0.11 and revenue of $1.11B for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio